missing translation for 'onlineSavingsMsg'
Learn More

CD5 Monoclonal Antibody (UCHT2), Super Bright™ 702, eBioscience™, Invitrogen™

Mouse Monoclonal Antibody

152.00 € - 341.00 €

Spezifikation

Antigen CD5
Klon UCHT2
Konzentration 5 μL/Test
Anwendungen Flow Cytometry
Klassifikation Monoclonal
Mehr Spezifikationen ansehen

Produkte 2
Produktcode Marke Menge Preis Menge & Verfügbarkeit  
Produktcode Marke Menge Preis Menge & Verfügbarkeit  
15913704
Unterlagen ansehen Aktionsdetails
Affymetrix eBioscience
67-0059-42
100 Tests
341.00 €
100 Stück
Alternative Produkte anzeigen
Sparen Sie bis zu 
»
Verfügbar ab: 03-06-2024
Sie sich ein, um den Lagerbestand zu sehen
Bitte Sie sich an, um diesen Artikel zu kaufen. Sie benötigen ein Web-Konto? Registrieren Sie sich noch heute!
15903704
Unterlagen ansehen Aktionsdetails
Affymetrix eBioscience
67-0059-41
25 Tests Dieser Artikel ist im Moment nicht verfügbar oder wird nicht mehr hergestellt.
Schauen Sie bitte auf unsere Produktseite nach möglichen Alternativen
N/A Alternative Produkte anzeigen
Sparen Sie bis zu 
»
Beschreibung

Beschreibung

Description: The eBio124-1D1 monoclonal antibody reacts with human CD7, also known as gp40 and Leu9. CD7, a 40 kD receptor, is a member of the immunoglobulin gene superfamily. The N-terminal amino acid sequence (aa1-107) is highly homologous to Ig kappa light chain sequence; while the carboxyl-terminal region of the extracellular domain is proline-rich and has been postulated to form a stalk from which the Ig domain projects. CD7 is expressed on the majority of immature and mature T lymphocytes, and T cell leukemias. It is also found on natural killer cells, a small suppopulation of normal B cells and on maligant B cells. Cross-linking surface CD7 positively modulates T cell and NK cell activity, as measured by calcium flux, expression of adhesion molecules, cytokine secretion and proliferation. CD7 associates directly with phosphoinositol 3'-kinase. CD7 ligation induces production of D-3 phosphoinositides and tyrosine phosphorylation. A clonogenic subpopulation of human CD34(+) CD38(-) cord blood cells that express CD45RA and HLA-DR and high levels of the CD7 has been reported. These cells possess the capacity for lymphopoiesis. They can generate B-cells, natural killer cells, and dendritic cells but do not possess the capacity to develop into myeloid cells or erythroid cells. The CD7(+) phenotype distinguishes primitive human lymphoid progenitors from pluripotent stem cells.

CD5 is a 67 kDa human T-lymphocyte single-chain transmembrane glycoprotein. CD5 is present on all mature T-lymphocytes, on most of thymocytes and on many T-cell leukemias and lymphomas. CD5 also reacts with a subpopulation of activated B-cells and may act as a receptor in regulating T-cell proliferation. CD5 is found on 95% of thymocytes and 72% of peripheral blood lymphocytes. In lymph nodes, the main reactivity is observed in T cell areas. CD5 is expressed by many T cell leukemia, lymphomas, and activated T cells. Diseases associated with CD5 dysfunction include thymus cancer and Richter's Syndrome.
Spezifikation

Spezifikation

CD5
5 μL/Test
Monoclonal
Liquid
RUO
P06127
IgG1 κ
Affinity chromatography
Antibody
UCHT2
Flow Cytometry
Super Bright 702
Mouse
Human
921
Primary
4° C, store in dark, DO NOT FREEZE!
Videos
Sicherheitsdatenblatt (SDS)
Dokumentation

Dokumentation

Produktzertifizierungen